Skip to main content

Peter Ho, M.D., Ph.D.

Peter Ho

Peter Ho


Beard Hall, 301 Pharmacy Lane, CB# 7355, Chapel Hill, NC, 27599

Peter Ho currently serves on the Board of Directors of Aravive Inc. and Celeris Therapeutics, the Scientific Advisory Boards of Accent Therapeutics and Tavotek Biotherapeutics, and the External Scientific Advisory Committee of the Cleveland Clinic Center for Therapeutics Discovery. His prior industry positions have included Senior VP of the Oncology Center of Excellence in Drug Discovery at GlaxoSmithKline, Chief Medical Officer at Epizyme Inc, and co-Founder and President of BeiGene, Ltd. He has overseen the development of over 60 hematology and oncology compounds which has led to eleven NCE or biologics approvals to date:  Gleevec®; Arranon®; Tykerb®; Promacta®; Votrient®; Synribo®; Tafinlar®; Mekinist®; Sylvant®; and Rydap®, and Tazverik®.